These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21401576)

  • 1. Epitope specificity of myeloperoxidase antibodies: identification of candidate human immunodominant epitopes.
    Bruner BF; Vista ES; Wynn DM; James JA
    Clin Exp Immunol; 2011 Jun; 164(3):330-6. PubMed ID: 21401576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of risk epitopes of anti-neutrophil antibody MPO-ANCA in vasculitis in Japanese population.
    Suzuki K; Kobayashi S; Yamazaki K; Gondo M; Tomizawa K; Arimura Y; Nakabayashi K; Ozaki S; Yoshida M; Yoshida T; Tsusaka N; Muso E; Okazaki T; Hashimoto H
    Microbiol Immunol; 2007; 51(12):1215-20. PubMed ID: 18094540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis.
    Free ME; Stember KG; Hess JJ; McInnis EA; Lardinois O; Hogan SL; Hu Y; Mendoza C; Le AK; Guseman AJ; Pilkinton MA; Bortone DS; Cowens K; Sidney J; Karosiene E; Peters B; James E; Kwok WW; Vincent BG; Mallal SA; Jennette JC; Ciavatta DJ; Falk RJ
    J Autoimmun; 2020 Jan; 106():102306. PubMed ID: 31383567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope analysis of anti-myeloperoxidase antibodies in propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.
    Wang C; Gou SJ; Xu PC; Zhao MH; Chen M
    Arthritis Res Ther; 2013; 15(6):R196. PubMed ID: 24252385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
    van der Geld YM; Stegeman CA; Kallenberg CG
    Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis.
    Roth AJ; Ooi JD; Hess JJ; van Timmeren MM; Berg EA; Poulton CE; McGregor J; Burkart M; Hogan SL; Hu Y; Winnik W; Nachman PH; Stegeman CA; Niles J; Heeringa P; Kitching AR; Holdsworth S; Jennette JC; Preston GA; Falk RJ
    J Clin Invest; 2013 Apr; 123(4):1773-83. PubMed ID: 23549081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epitope analysis of myeloperoxidase-specific antineutrophil cytoplasmic autoantibodies (MPO-ANCA) in childhood onset Graves' disease treated with propylthiouracil.
    Fujieda M; Suzuki K; Sato H; Hattori M; Wada N; Tsuchiya M; Okamoto N; Murata T; Matsudaira M; Shimizu M; Ohta K; Naruse K; Sugihara S; Wakiguchi H
    Clin Nephrol; 2005 Jun; 63(6):437-45. PubMed ID: 15960145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.
    Gou SJ; Xu PC; Chen M; Zhao MH
    PLoS One; 2013; 8(4):e60530. PubMed ID: 23577119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
    Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
    Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].
    Zhang L; Shuai Z; Hu Z; Zhang M; Chen S
    Zhonghua Nei Ke Za Zhi; 2015 Jun; 54(6):511-6. PubMed ID: 26359012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule.
    Ye H; Zhao MH; Gao Y; Guo XH; Wang HY
    Clin Exp Immunol; 2004 Oct; 138(1):179-82. PubMed ID: 15373922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the characteristics of circulating anti-myeloperoxidase autoantibodies in vasculitis with those in non-vasculitic conditions.
    Locke IC; Leaker B; Cambridge G
    Clin Exp Immunol; 1999 Feb; 115(2):369-76. PubMed ID: 9933467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers.
    Erdbrügger U; Hellmark T; Bunch DO; Alcorta DA; Jennette JC; Falk RJ; Nachman PH
    Kidney Int; 2006 May; 69(10):1799-805. PubMed ID: 16557221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some patients with anti-myeloperoxidase autoantibodies have a C-ANCA pattern.
    Segelmark M; Baslund B; Wieslander J
    Clin Exp Immunol; 1994 Jun; 96(3):458-65. PubMed ID: 7516271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies.
    Audrain MA; Baranger TA; Moguilevski N; Martin SJ; Devys A; Lockwood CM; Muller JY; Esnault VL
    Clin Exp Immunol; 1997 Jan; 107(1):127-34. PubMed ID: 9010267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasmic antibodies target sequential functional proteinase 3 epitopes in the sera of patients with Wegener’s granulomatosis.
    Bruner BF; Vista ES; Wynn DM; Harley JB; James JA
    Clin Exp Immunol; 2010 Nov; 162(2):262-70. PubMed ID: 21077276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase.
    Falk RJ; Becker M; Terrell R; Jennette JC
    Clin Exp Immunol; 1992 Aug; 89(2):274-8. PubMed ID: 1379133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis.
    Xu PC; Cui Z; Chen M; Hellmark T; Zhao MH
    Rheumatology (Oxford); 2011 Jul; 50(7):1236-43. PubMed ID: 21372002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis.
    Short AK; Lockwood CM
    Clin Exp Immunol; 1997 Nov; 110(2):270-6. PubMed ID: 9367412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.